Pharmaceutical Tech

May262016 by Pharmaceutical TechNo Comments

China Restructures its Drug Pricing Regime

Economic and Regional Development, Pharmaceutical Purchasing

In early May 2015, China’s National Development and Reform Commission (“NDRC”), together with six other agencies, issued aCircular Concerning Opinions on Advancing the Drug Pricing Reform (“Opinions”).1 The Opinions initiate a groundbreaking reform of the drug pricing system in China. Until now, pursuant to China’s Drug Administration Law and related policies and regulations, the government has either set specific prices, or set price ceilings, i.e., maximum retail prices (“MRPs”), for many drugs in China, including those that are reimbursed via its state- run insurance plans. The Opinions remove many of the constraints on drug prices, permitting those prices to be set by the market, and also provide some details of a planned reform to better set reimbursement standards and rates for drugs...

May192016 by Pharmaceutical TechNo Comments

Drugs Shortage and its Impact on Counterfeit Drugs

Drug Counterfeiting, Economic and Regional Development, Pharmaceutical Distribution and Logistics

Drugs Shortage Though the word shortage refers to the availability of less, its presence is not clinging to its meaning by swirling around the world with a strong presence, yet another area shadowing by 'shortage' is drugs. The world that has been witnessing the shortage of food and shelter is also taking into its account the shortage of drugs, several hospitals and pharmacies are heading into this dire problem and experiencing a gamut of serious health issues. If scarcity is drugs shortage renowned face then the other intimidating face is the raise of counterfeits. The short fall of drugs apparently become the lifeblood of thought to produce counterfeits which causes serious illness and sometimes even death can speak with the voice of counterfeit medicines. The usage of counterfeit drug...

May122016 by Pharmaceutical TechNo Comments

Experience World-Class Events in Healthcare

Pharma Conventions, Pharmaceutical Events

Work hard and play hard in one of the most exciting destinations in the world. Singapore’s critical mass of healthcare expertise, strategic location and business-friendly environment fosters international healthcare events that are second to none, and the city’s exhilarating mix of leisure activities will make you never want to leave. The ideal setting for healthcare events, Singapore is where the world’s foremost medical experts go to widen their horizons. Asia’s biomedical, pharmaceutical and healthcare providers are gearing up for a surge in demand as the region’s population grows larger, richer and older. At the same time, the Asian governments are equally challenged to deliver efficient, affordable and quality care. Singapore is at the frontier of healthcare in Asia, having attract...

May52016 by Pharmaceutical TechNo Comments

Prescription Drug Abuse Statistics and Effects

Pharmaceutical Chemicals and Intermediates, Pharmaceutical Excipients and Drug Formulation

More than 3.8 percent of the global population use marijuana i.e. 158.8 million people, relying on the United Nations statistics but do you know over the counter drugs and prescription have lined up next to marijuana among the common abused substances! There are a lot of people participating in the prescription drug abuse without risks taking into account – risks vary with the type of the medicine and its dose. Prescription Drug Abuse Involving to the risk of taking prescription medication that isn't pertain to yours or changing the prescription medication or the dose of the medicine is what termed to be Prescription Drug Abuse. A study revealed nearly 16 million people abuse prescription medication in the U.S, and about 2,500 youth (12 to 17) is abusing pain reliever for the first time ...

Apr302016 by Pharmaceutical TechNo Comments

Productivity Ramps Up With Indian Pharmaceutical Cluster

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

Introduction The Indian Pharma Inc. ranks 5 in the pharma sector globally. The ranking is in terms of volume of production. This ranking and establishment accounts for 10% of global production and gives India recognition worldwide in the pharmaceutical sector. Considering the depth of the pharma industry in India, the turnover itself speaks of large numbers. During the 1980s what started as US $ 0.3 Million industry now proudly stands at a turnover of US $ 65 Billion. Considering the huge capital and turnover of the industry and according to the Department of Pharmaceuticals, the Indian pharmaceutical industry employs about 340,000 people and an estimated 400,000 doctors and 300,000 chemists. Industry structure The Indian pharmaceutical industry is fragmented with thousands of manufac...

Apr252016 by Pharmaceutical TechNo Comments

Canada to Donate Vaccine for Ebola to West Africa

Economic and Regional Development, Medicine, Vaccinations and Antidotes

By now, the Ebola virus has clasped its tentacles across West Africa and is beginning to show its tooth in the developed world. The Public Health Agency of Canada and the federal government have begun to share details about a vaccine that’s part of an experiment. The aim is to arrive at the Ebola vaccine which is supposed to be a donation to the people of Africa who have been subject Dr Gary Kobinger who is chief of the special pathogens at the agency as also the Heritage Minister Shelly Glover declared of such a development and made more information available at a news conference in Winnipeg recently. We have tried to accumulate as much information about the vaccine as we could- No. of doses that will be sent It has been made public that Canada will be donating anything between 800 to...

Apr192016 by Pharmaceutical TechNo Comments

Clinical Trials on tissues of human heart now possible in UK

Biotechnology, Clinical Trials, Drug Development, Pharmaceutical Research and Development

A UK based new start-up is developing a unique method for testing out the impact of drugs on the cardio-vascular system without resorting to animal testing or through clinical trials of an early-stage human. The company we are talking about is Inocardia, a spin-out from the University of Coventry. Having attracted sufficient funding from the Mercia Fund Management, this organization is still in the process of shaping up the model and commercializing their line of business. The model that they use takes up samples of the human heart attached to a rig. The cardiac tissue is elongated and contracted through electric impulse stimulation so as to mimic a working human heart.Drugs to be trialed are then administered to the tissue to keep a track of adverse effects – a test that could have been...

Apr152016 by Pharmaceutical TechNo Comments

Preventing HIV/AIDS by Using Liquid Silicone Rubber

Cure & Prevention, Pharmaceutical Research and Development

HIV/AIDS. True that it isn’t much talked about these days as cancer. But the World Health Organisation still bears data that shows about 34 million people around the globe in 2011 managed to breathe air carrying this disease and 1.7 million lost their lives. It is definitely one of the most fatal diseases that has engulfed humanity since it was first detected. There could be some good news: a relatively recent tool that could help to fight back HIV/AIDS is known to be in the Stage III clinical testing being carried out by the US FDA. It constitutes an anti-viral drug that is mixed in a two-component liquid silicone rubber (LSR) that is injection molded into a vaginal ring that releases the drug. A highly advanced combining process was customized for this drug. The machine, metering syst...

Apr102016 by Pharmaceutical TechNo Comments

What Can Recent Mergers Mean for the Future of Pharmaceutical Industry?

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

Expensive pharmaceutical deals in the industry are in a mad fury of alliances this year on account of the patent expiries that big drug companies are faced with. In an attempt to make up for the losses, hence, these companies are teaming up with their better off competitors. The world’s most well-known drug maker, Pfizer and London’s AstraZeneca have been heard to contemplate joining hands in a potential $100 billion epic merger which is a sign that the pharmaceutical sector is brimming with many more such deals in the days to come. Mergermarket, the famous research firm, shows data that suggest that five pharmacy deals valuing more than $2 billion in the first four months of 2014 are of the same momentum possibly, like seven deals of the same value that were announced in the entire year...

Apr72016 by Pharmaceutical TechNo Comments

Low-Cost Genome Sequencing

BioPharma, Biotechnology, Cheminformatics, Drug Development, Drug Discovery, Economic and Regional Development, Pharma Industry

In Silicon Valley, Moore's law appears to remained on equivalent balance with the regular laws classified by Isaac Newton. Intel prime supporter Gordon Moore's notorious perception that registering power has a tendency to twofold — and that its value hence parts — like clockwork has held valid for about 50 years with just minor update. Yet as a model of quick transform, it is the focus of energetic ill-use from genome analysts. In many presentations over the past few years, researchers have contrasted the slant of Moore's law and the quickly dropping expenses of DNA sequencing. For some time they kept pace, however since something like 2007, it has not even been close. The cost of sequencing a normal human genome has plunged from about Us$10 million to a couple of thousand dollars in only...